NEW YORK (Reuters Health) — Protein profiles identified through proteomics in early-stage chronic lymphocytic leukemia (CLL) show promise in discriminating
Read more
Home »
chronic lymphocytic leukemia
GENUINE Improvements: Ublituximab Plus Ibrutinib for CLL
Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease associated with several known genetic abnormalities, including 17p deletion (del[17p]), 11q
Read more